• 1
    Barrett MG, Belinsky GS, Tashjian AH Jr 1997 A new action of parathyroid hormone. Receptor-mediated stimulation of extracellular acidification in human osteoblast-like SaOS-2 cells. J Biol Chem 272: 2634626353.
  • 2
    Bodine PVN, Komm BS 1999 Evidence that conditionally immortalized human osteoblasts express an osteocalcin receptor. Bone 25: 535543.
  • 3
    McConnell HM, Owicki JC, Parce JW, Miller DL, Baxter GT, Wada HG, Pitchford S 1992 The cytosensor microphysiometer: Biological applications of silicon technology. Science 257: 19061912.
  • 4
    Chio CL, Drong RF, Riley DT, Gill GS, Slightom JL, Huff RM 1994 D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells. J Biol Chem 269: 1181311819.
  • 5
    Fukayama S, Bosma TJ, Goad DL, Voelkel EF, Tashjian AH Jr 1988 Human parathyroid hormone (PTH)-related protein and human PTH: Comparative biological activities on human bone cells and bone resorption. Endocrinology 123: 28412848.
  • 6
    Lerner UH, Ransjo M, Sahlberg K, Ljunggren O, Fredholm BB 1989 Forskolin sensitizes parathyroid hormone-induced cyclic AMP response, but not the bone resorptive effect, in mouse calvarial bones. Bone Miner 5: 169181.
  • 7
    Dunlay R, Hruska K 1990 PTH receptor coupling to phospholipase C is an alternate pathway of signal transduction in bone and kidney. Am J Physiol 258: F223F231.
  • 8
    Ferrier J, Kesthely A, Xia S-L 1992 Hormone responses of in vitro bone nodule cells: Studies on changes of intracellular calcium and membrane potential in response to parathyroid hormone and calcitonin. Bone Miner 19: 103116.
  • 9
    Potts JT Jr, Bringhurst FR, Gardella T, Nussbaum S, Segre G, Kronenberg H 1995 Parathyroid hormone: Physiology, chemistry, biosynthesis, secretion, metabolism, and mode of action. In: DeGrootLJ (ed.) Endocrinology, 3rd ed., vol. 2. W. B. Saunders, Philadelphia, PA, U.S.A., pp. 920966
  • 10
    Lanske B, Divieti P, Kovacs CS, Pirro A, Landis WJ, Krane SM, Bringhurst FR, Kronenberg HM 1998 The parathyroid hormone (PTH)/PTH-related peptide receptor mediates actions of both ligands in murine bone. Endocrinology 139: 51945204.
  • 11
    Whitfield JF, Morley P 1995 Small bone-building fragments of parathyroid hormone: New therapeutic agents for osteoporosis. Trends Pharmacol Sci 16: 382386.
  • 12
    Hodsman AB, Fraher LJ 1990 Biochemical responses to sequential human parathyroid hormone (1-38) and calcitonin in osteoporotic patients. Bone Miner 9: 137152.
  • 13
    Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 95: 35973602.
  • 14
    Goldhaber P, Rabadjija L 1987 H+ stimulation of cell-mediated bone resorption in tissue culture. Am J Physiol 253: E90E98.
  • 15
    Krieger NS, Sessler NE, Bushinsky DA 1992 Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro. Am J Physiol 262: F442F448.
  • 16
    Arnett TR, Spowage M 1996 Modulation of the resorptive activity of rat osteoclasts by small changes in extracellular pH near the physiological range. Bone 18: 277279.
  • 17
    Barnicot NA 1947 The supravital staining of osteoclasts with neutral-red: Their distribution on the parietal bone of normal growing mice, and a comparison with the mutants grey-lethal and hydrocephalus-3. Proc R Soc Lond B Biol Sci 134: 467485.
  • 18
    Beavo JA, Rogers NL, Crofford OB, Hardman JG, Sutherland EW, Newman EV 1970 Effects of xanthine derivatives on lipolysis and on adenosine 3′,5′-monophosphate phosphodiesterase activity. Mol Pharmacol 6: 597603.
  • 19
    Neuman WF, Firschein H, Chen PSJ, Mulryan BJ, DiStefano V 1956 On the mechanism of action of parathormone. J Am Chem Soc 78.3: 38633864.
  • 20
    Goldman ME, Chorev M, Reagan JE, Nutt RF, Levy JJ, Rosenblatt M 1988 Evaluation of novel parathyroid hormone analogs using a bovine renal membrane receptor binding assay. Endocrinology 123: 14681475.
  • 21
    Ohba Y, Ohba T, Sumitani K, Tagami-Kondoh K, Hiura K, Miki Y, Kakegawa H, Takano-Yamamoto T, Katunuma N 1996 Inhibitory mechanisms of H(+)-ATPase inhibitor bafilomycin A1 and carbonic anhydrase II inhibitor acetazolamide on experimental bone resorption. FEBS Lett 387: 175178.